193 related articles for article (PubMed ID: 17974959)
1. RasGRP1 overexpression in the epidermis of transgenic mice contributes to tumor progression during multistage skin carcinogenesis.
Luke CT; Oki-Idouchi CE; Cline JM; Lorenzo PS
Cancer Res; 2007 Nov; 67(21):10190-7. PubMed ID: 17974959
[TBL] [Abstract][Full Text] [Related]
2. Transgenic overexpression of RasGRP1 in mouse epidermis results in spontaneous tumors of the skin.
Oki-Idouchi CE; Lorenzo PS
Cancer Res; 2007 Jan; 67(1):276-80. PubMed ID: 17210708
[TBL] [Abstract][Full Text] [Related]
3. RasGRP1 is essential for ras activation by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate in epidermal keratinocytes.
Sharma A; Luke CT; Dower NA; Stone JC; Lorenzo PS
J Biol Chem; 2010 May; 285(21):15724-30. PubMed ID: 20308057
[TBL] [Abstract][Full Text] [Related]
4. RasGRP1 represents a novel non-protein kinase C phorbol ester signaling pathway in mouse epidermal keratinocytes.
Rambaratsingh RA; Stone JC; Blumberg PM; Lorenzo PS
J Biol Chem; 2003 Dec; 278(52):52792-801. PubMed ID: 14532295
[TBL] [Abstract][Full Text] [Related]
5. Targeted deletion of RasGRP1 impairs skin tumorigenesis.
Sharma A; Fonseca LL; Rajani C; Yanagida JK; Endo Y; Cline JM; Stone JC; Ji J; Ramos JW; Lorenzo PS
Carcinogenesis; 2014 May; 35(5):1084-91. PubMed ID: 24464785
[TBL] [Abstract][Full Text] [Related]
6. RasGRP1 transgenic mice develop cutaneous squamous cell carcinomas in response to skin wounding: potential role of granulocyte colony-stimulating factor.
Diez FR; Garrido AA; Sharma A; Luke CT; Stone JC; Dower NA; Cline JM; Lorenzo PS
Am J Pathol; 2009 Jul; 175(1):392-9. PubMed ID: 19497993
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of bryostatin 1 and 12-O-tetradecanoylphorbol-13-acetate on the regulation and activation of RasGRP1 in mouse epidermal keratinocytes.
Tuthill MC; Oki CE; Lorenzo PS
Mol Cancer Ther; 2006 Mar; 5(3):602-10. PubMed ID: 16546974
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis.
Chan KS; Carbajal S; Kiguchi K; Clifford J; Sano S; DiGiovanni J
Cancer Res; 2004 Apr; 64(7):2382-9. PubMed ID: 15059889
[TBL] [Abstract][Full Text] [Related]
10. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
[TBL] [Abstract][Full Text] [Related]
11. Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis.
Cataisson C; Ohman R; Patel G; Pearson A; Tsien M; Jay S; Wright L; Hennings H; Yuspa SH
Cancer Res; 2009 Jan; 69(1):319-28. PubMed ID: 19118017
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of protein kinase C-alpha in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion.
Wang HQ; Smart RC
J Cell Sci; 1999 Oct; 112 ( Pt 20)():3497-506. PubMed ID: 10504298
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion.
DiGiovanni J; Bol DK; Wilker E; Beltrán L; Carbajal S; Moats S; Ramirez A; Jorcano J; Kiguchi K
Cancer Res; 2000 Mar; 60(6):1561-70. PubMed ID: 10749124
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis.
Budunova IV; Kowalczyk D; Pérez P; Yao YJ; Jorcano JL; Slaga TJ
Oncogene; 2003 May; 22(21):3279-87. PubMed ID: 12761498
[TBL] [Abstract][Full Text] [Related]
15. CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling.
Zhu S; Yoon K; Sterneck E; Johnson PF; Smart RC
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):207-12. PubMed ID: 11756662
[TBL] [Abstract][Full Text] [Related]
16. v-Ha-ras-induced mouse skin papillomas exhibit aberrant expression of keratin K13 as do their 7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate -induced analogues.
Sutter C; Strickland JE; Welty DJ; Yuspa SH; Winter H; Schweizer J
Mol Carcinog; 1991; 4(6):467-76. PubMed ID: 1724371
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
[TBL] [Abstract][Full Text] [Related]
19. IL-1 alpha, innate immunity, and skin carcinogenesis: the effect of constitutive expression of IL-1 alpha in epidermis on chemical carcinogenesis.
Murphy JE; Morales RE; Scott J; Kupper TS
J Immunol; 2003 Jun; 170(11):5697-703. PubMed ID: 12759452
[TBL] [Abstract][Full Text] [Related]
20. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
Shibata MA; Ward JM; Green JE; Merlino G
Mol Carcinog; 1997 Mar; 18(3):160-70. PubMed ID: 9115586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
